Marksans Pharma Ltd
NSE:MARKSANS

Watchlist Manager
Marksans Pharma Ltd Logo
Marksans Pharma Ltd
NSE:MARKSANS
Watchlist
Price: 308.3 INR 0.85% Market Closed
Market Cap: 139.7B INR
Have any thoughts about
Marksans Pharma Ltd?
Write Note

Marksans Pharma Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Marksans Pharma Ltd
Revenue Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Marksans Pharma Ltd
NSE:MARKSANS
Revenue
â‚ą22.7B
CAGR 3-Years
18%
CAGR 5-Years
18%
CAGR 10-Years
13%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Revenue
â‚ą289.5B
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Revenue
â‚ą265.1B
CAGR 3-Years
8%
CAGR 5-Years
10%
CAGR 10-Years
10%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Revenue
â‚ą503.1B
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
8%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Revenue
â‚ą112.2B
CAGR 3-Years
11%
CAGR 5-Years
7%
CAGR 10-Years
9%
M
Mankind Pharma Ltd
NSE:MANKIND
Revenue
â‚ą103.3B
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Marksans Pharma Ltd's Revenue?
Revenue
22.7B INR

Based on the financial report for Jun 30, 2024, Marksans Pharma Ltd's Revenue amounts to 22.7B INR.

What is Marksans Pharma Ltd's Revenue growth rate?
Revenue CAGR 10Y
13%

Over the last year, the Revenue growth was 18%. The average annual Revenue growth rates for Marksans Pharma Ltd have been 18% over the past three years , 18% over the past five years , and 13% over the past ten years .

Back to Top